Free Trial
NASDAQ:SGRY

Surgery Partners Q2 2025 Earnings Report

Surgery Partners logo
$22.04 -0.23 (-1.03%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$22.41 +0.37 (+1.68%)
As of 04:19 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Surgery Partners EPS Results

Actual EPS
N/A
Consensus EPS
$0.16
Beat/Miss
N/A
One Year Ago EPS
N/A

Surgery Partners Revenue Results

Actual Revenue
N/A
Expected Revenue
$816.96 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Surgery Partners Announcement Details

Quarter
Q2 2025
Time
Before Market Opens
Conference Call Date
Tuesday, August 5, 2025
Conference Call Time
8:30AM ET

Conference Call Resources

Surgery Partners Earnings Headlines

Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.
SGRY Surgery Partners, Inc. - Seeking Alpha
See More Surgery Partners Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Surgery Partners? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Surgery Partners and other key companies, straight to your email.

About Surgery Partners

Surgery Partners (NASDAQ:SGRY) (NASDAQ: SGRY), founded in 2010 and headquartered in Nashville, Tennessee, is a leading provider of surgical healthcare services in the United States. The company offers a comprehensive platform that supports the development, acquisition and management of ambulatory surgery centers, surgical hospitals and diagnostic and imaging facilities. Surgery Partners focuses on delivering high-quality, cost-effective care by combining clinical expertise with streamlined operations.

The company partners closely with physicians across a wide range of specialties, including orthopedics, ophthalmology, gastroenterology, pain management and urology. Through these partnerships, Surgery Partners assists in site selection, facility design and construction, regulatory compliance and ongoing operational management. Its vertically integrated model encompasses not only surgical and imaging services but also revenue cycle management and supply chain coordination, helping physician practices and hospital systems optimize performance.

Since its inception, Surgery Partners has grown through a strategic mix of de novo development and targeted acquisitions, expanding its presence in both metropolitan and mid‐sized markets. Today, the company operates a network of ambulatory surgery centers, surgical hospitals and diagnostic facilities spanning more than two dozen states. This geographic diversification allows Surgery Partners to serve a broad patient base while maintaining strong relationships with local physician groups and health systems.

Under the leadership of President and Chief Executive Officer Tony Strange and a seasoned executive team, Surgery Partners emphasizes clinical quality, patient safety and operational excellence. The company leverages standardized protocols and data-driven performance metrics to drive continuous improvement, and it works with accrediting bodies and payers to support value‐based care initiatives. With a focus on sustainable growth and enhanced patient outcomes, Surgery Partners aims to be a trusted partner for physicians, health systems and communities nationwide.

View Surgery Partners Profile

More Earnings Resources from MarketBeat